The association between N-methylnaltrexone, a peripherally acting mu-opioid receptor antagonist, and clinical outcomes in patients undergoing robotic-assisted radical cystectomy

1870 ALVIMOPAN, A PERIPHERALLY ACTING MU-OPIOID RECEPTOR ANTAGONIST, ACCELERATES GASTROINTESTINAL RECOVERY AND DECREASES LENGTH OF HOSPITAL STAY AFTER RADICAL CYSTECTOMY

The Journal of Urology ◽

10.1016/j.juro.2013.02.2289 ◽

2013 ◽

Vol 189 (4S) ◽

Cited By ~ 4

Author(s):

Ashish M Kamat ◽

Sam S Chang ◽

Cheryl Lee ◽

Gilad Amiel ◽

Timothy Beard ◽

...

Keyword(s):

Hospital Stay ◽

Receptor Antagonist ◽

Radical Cystectomy ◽

Opioid Receptor ◽

Length Of Hospital Stay ◽

Mu Opioid Receptor ◽

Mu Opioid ◽

Faculty Opinions recommendation of The selective mu-opioid receptor antagonist ADL5510 reduces levodopa-induced dyskinesia without affecting antiparkinsonian action in MPTP-lesioned macaque model of Parkinson's disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.9987957.10722055 ◽

2011 ◽

Author(s):

Alfredo Berardelli ◽

Antonio Suppa

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Receptor Antagonist ◽

Opioid Receptor ◽

Mu Opioid Receptor ◽

Mu Opioid ◽

Macaque Model ◽

Naloxonazine, a specific mu-opioid receptor antagonist, attenuates the increment of locomotor activity induced by acute methamphetamine in mice

Toxicology Letters ◽

10.1016/j.toxlet.2012.04.022 ◽

2012 ◽

Vol 212 (1) ◽

pp. 61-65 ◽

Cited By ~ 5

Author(s):

Chih-Cheng Chien ◽

Yih-Jing Lee ◽

Lir-Wan Fan ◽

Ing-Kang Ho ◽

Lu-Tai Tien

Keyword(s):

Locomotor Activity ◽

Receptor Antagonist ◽

Opioid Receptor ◽

Mu Opioid Receptor ◽

Mu Opioid ◽

Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery

Surgical Endoscopy ◽

10.1007/s00464-005-0104-y ◽

2005 ◽

Vol 20 (1) ◽

pp. 64-70 ◽

Cited By ~ 133

Author(s):

E. R. Viscusi ◽

S. Goldstein ◽

T. Witkowski ◽

A. Andonakakis ◽

R. Jan ◽

...

Keyword(s):

Abdominal Surgery ◽

Receptor Antagonist ◽

Opioid Receptor ◽

Postoperative Ileus ◽

Mu Opioid Receptor ◽

Major Abdominal Surgery ◽

Mu Opioid ◽

Novel endomorphin-2 analogs with mu-opioid receptor antagonist activity

Journal of Peptide Research ◽

10.1111/j.1399-3011.2005.00282.x ◽

2005 ◽

Vol 66 (3) ◽

pp. 125-131 ◽

Cited By ~ 9

Author(s):

R. Kruszynski ◽

J. Fichna ◽

J.-C. do-Rego ◽

N.N. Chung ◽

P.W. Schiller ◽

...

Keyword(s):

Receptor Antagonist ◽

Opioid Receptor ◽

Mu Opioid Receptor ◽

Antagonist Activity ◽

Mu Opioid ◽

Agonist‐Dependent Modulation by the Long‐Acting Mu Opioid Receptor Antagonist, Methocinnamox (MCAM)

The FASEB Journal ◽

10.1096/fasebj.2020.34.s1.06832 ◽

2020 ◽

Vol 34 (S1) ◽

pp. 1-1

Author(s):

Hudson R. Smith ◽

Joshua C. Zamora ◽

Teresa S. Chavera ◽

Elaine M. Jennings ◽

Gail D. Winger ◽

...

Keyword(s):

Receptor Antagonist ◽

Opioid Receptor ◽

Mu Opioid Receptor ◽

Mu Opioid ◽

Long Acting

The peripherally-acting mu-opioid receptor antagonist alvimopan* effectively reduces the time to recovery of GI function after bowel resection,

Inpharma Weekly ◽

10.2165/00128413-200615250-00015 ◽

2006 ◽

Vol &NA; (1525) ◽

pp. 6

Author(s):

&NA;

Keyword(s):

Receptor Antagonist ◽

Opioid Receptor ◽

Bowel Resection ◽

Mu Opioid Receptor ◽

Mu Opioid ◽

Modulation of Gastrointestinal Function by MuDelta, a mixed Mu Opioid Receptor Agonist/Delta Opioid Receptor Antagonist

The FASEB Journal ◽

10.1096/fasebj.26.1_supplement.lb766 ◽

2012 ◽

Vol 26 (S1) ◽

Author(s):

Pamela J Hornby

Keyword(s):

Receptor Antagonist ◽

Opioid Receptor ◽

Receptor Agonist ◽

Mu Opioid Receptor ◽

Delta Opioid Receptor ◽

Gastrointestinal Function ◽

Mu Opioid ◽

Opioid Receptor Agonist

Nalbuphine, a kappa opioid receptor agonist and mu opioid receptor antagonist attenuates pruritus, decreases IL-31, and increases IL-10 in mice with contact dermatitis

European Journal of Pharmacology ◽

10.1016/j.ejphar.2019.172702 ◽

2019 ◽

Vol 864 ◽

pp. 172702 ◽

Cited By ~ 8

Author(s):

Saadet Inan ◽

Alvaro Torres-Huerta ◽

Liselotte E. Jensen ◽

Nae J. Dun ◽

Alan Cowan

Keyword(s):

Contact Dermatitis ◽

Receptor Antagonist ◽

Opioid Receptor ◽

Receptor Agonist ◽

Mu Opioid Receptor ◽

Kappa Opioid Receptor ◽

Kappa Opioid ◽

Mu Opioid ◽

Opioid Receptor Agonist

Lessons learned from using fMRI in the early clinical development of a mu-opioid receptor antagonist for disorders of compulsive consumption

Psychopharmacology ◽

10.1007/s00213-019-05427-5 ◽

2020 ◽

Author(s):

Pradeep J. Nathan ◽

Geor Bakker

Keyword(s):

Receptor Antagonist ◽

Opioid Receptor ◽

Mu Opioid Receptor ◽

Clinical Development ◽

Lessons Learned ◽

Mu Opioid ◽

Compulsive Consumption ◽

Early Clinical Development